Exact Mass: 319.0042
Exact Mass Matches: 319.0042
Found 139 metabolites which its exact mass value is equals to given mass value 319.0042
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
ONO-2235; ONO 2235; ONO2235; Sorbistat
2-(1,3-benzoxazol-2-ylsulfanyl)-N-(1,3-thiazol-2-yl)butanamide
Hernandonine
An oxoaporphine alkaloid isolated from Hernandia ovigera and Lindera chunii and has been shown exhibit inhibitory activity against HIV-1 integrase .
Cassameridine
An oxoaporphine alkaloid that is 7H-dibenzo[de,g]quinolin-7-one which is substituted by methylenedioxy grups at the 1,2 and 9,10 positions. Compared with liriodenine, which lacks the 9,10-methylenedioxy group, cassameridine displays only moderate antifungal activity.
Epalrestat
C471 - Enzyme Inhibitor > C72880 - Aldose Reductase Inhibitor D004791 - Enzyme Inhibitors
4-(4,5-dichloro-6-oxopyridazin-1-yl)benzenesulfonamide
(R)-2-(4-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
Cetophenicol
C254 - Anti-Infective Agent > C52588 - Antibacterial Agent
3-bromo-4-[(4-methylphenyl)methylamino]benzoic acid
(S)-2-(4-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
1-(3-Bromo-5-methylpyridin-2-yl)-4-ethylpiperazine hydrochloride
2-methyl-3-sulfobutyl-5-chlorobenzothiazolium, inner salt
2-(2-(4-BROMO-1H-PYRAZOL-1-YL)ETHYL)ISOINDOLINE-1,3-DIONE
6,7-Difluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid
2-amino-2-(3,4-dichlorophenyl)-3-[(2-methylpropan-2-yl)oxy]-3-oxopropanoic acid
Bupropion hydrobromide
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
4-(4-chloro-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one
Astat
D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives C254 - Anti-Infective Agent > C514 - Antifungal Agent
3-amino-6-phenyl-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carbonitrile
5-BROMO-3-(2-PYRIDIN-2-YL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE
5-BROMO-3-(2-PYRIDIN-3-YL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE
4-(4-Bromophenyl)piperidine-4-carboxylic acid hydrochloride
7-(1,3-Benzothiazol-2-yl)-6-hydroxy-4-oxo-1,4-dihydro-3-quinoline carbonitrile
5-[3,5-Bis(trifluoromethyl)phenyl]-3-pyridinecarbaldehyde
ETHYL1-(4-BROMOPHENYL)-5-CYANO-1H-PYRAZOLE-4-CARBOXYLATE
(S)-2-(2-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
N-(4-Chlorobenzoyloxy)-4-nitrobenzimidamide
4-Chloro-6-(trifluoromethoxy)quinoline-3-carboxylic acid ethyl ester
1-(3-Bromophenyl)-2-[(2-methyl-2-propanyl)amino]-1-propanone hydr ochloride (1:1)
(R)-2-(2-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
4-(6-Bromo-4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)-2-pyrimidinamine
(2S,4R)-4-(2-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
(2S,4R)-4-(3-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
(2S,4R)-4-(4-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
(S)-2-(3-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
(R)-2-(3-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
n-(2-(4-bromophenoxy)ethyl)piperidine hydrochloride
4-(3-Chloro-2-fluoroanilino)-6-hydroxy-7- methoxyquinazoline
4-(chloromethyl)-2-(4-ethoxy-3-methoxyphenyl)-1,3-thiazole hydrochloride
2-Propanesulfinamide, N-[1-(5-bromo-2-fluorophenyl)ethylidene]-2-methyl-, [N(E),S(S)]-
FAAH-IN-2
FAAH-IN-2 (O-Desmorpholinopropyl Gefitinib) is a potent FAAH(fatty acid amide hydrolase) inhibitor extracted from Patent WO/2008/100977A2.